Finance

Lists
003020:SHE
Hefei Lifeon Pharmaceutical Co Ltd
CNÂ¥17.26
+1.83%
(+0.31) 1D
Sep 30, 3:04:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003020...
Open
CNÂ¥17.29
High
CNÂ¥17.44
Low
CNÂ¥16.89
Mkt. cap
3.94B
Avg. vol.
5.22M
Volume
0.00
Dividend
2.41%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 29, 2026
P/E ratio
24.12
52-wk high
CNÂ¥27.01
52-wk low
CNÂ¥14.20
EPS
CNÂ¥0.72
Shares outstanding
228.22M
No. of employees
1K
Open
CNÂ¥17.29
High
CNÂ¥17.44
Low
CNÂ¥16.89
Mkt. cap
3.94B
Avg. vol.
5.22M
Volume
0.00
Dividend
2.41%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 29, 2026
P/E ratio
24.12
52-wk high
CNÂ¥27.01
52-wk low
CNÂ¥14.20
EPS
CNÂ¥0.72
Shares outstanding
228.22M
No. of employees
1K
News stories
From web sources and news partners
About Hefei Lifeon Pharmaceutical Co Ltd
CEO-
Employees1.46K
FoundedJul 16, 2002
Headquarters-
SectorPharmaceutical industry
Websitelifeon.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
348.25M
473.12M
357.10M
327.16M
Cost of goods sold
112.98M
179.98M
121.91M
110.48M
Cost of revenue
112.98M
179.98M
121.91M
110.48M
Research and development expenses
19.45M
39.36M
18.38M
24.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
171.75M
215.72M
170.83M
137.12M
Operating expense
195.72M
262.92M
193.88M
169.72M
Total operating expenses
308.69M
442.90M
315.80M
280.20M
Operating income
39.55M
30.22M
41.30M
46.96M
Other non operating income
-544.58K
604.09K
-537.41K
412.91K
EBT including unusual items
35.98M
44.93M
41.31M
54.17M
EBT excluding unusual items
40.71M
30.20M
40.63M
50.19M
Income tax expense
4.40M
4.49M
6.05M
4.34M
Effective tax rate
12.23%
10.00%
14.65%
8.01%
Other operating expenses
5.15M
7.85M
4.63M
6.22M
Net income
30.71M
44.25M
35.29M
52.91M
Net profit margin
8.82%
9.35%
9.88%
16.17%
Earnings per share
-
-
-
-
Interest and investment income
1.69M
692.37K
264.54K
3.60M
Interest expense
-
-1.26M
-399.14K
-685.13K
Net interest expenses
1.69M
-564.11K
-134.59K
2.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
58.28M
51.18M
62.27M
69.21M
Gain or loss from assets sale
1.77K
1.68K
-
-49.79K
AI content may include mistakes. Learn more
Google apps